Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-07 · accession 0001209191-21-055291 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-09 | 2021-09-07+ | ORIC | Chacko Jacob | Pres, CEO, Dir | S - Sale | $25.11 | -6,181 | 16.6K | -27% | -$155.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | S | D | 5,981 | $25.11 | 16,751 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 5,981 shares sold in the price range of $25.00 to $25.295 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2021-09-08 | S | D | 200 | $25.04 | 16,551 | D | — | — | (F3) Represents the weighted average share price of an aggregate total of 200 shares sold in the price range of $25.00 to $25.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |